NCT05604716

Brief Summary

An observational cross-sectional follow-up study on the quality of life (two aspects, digestive physiological and social psychological functions) of solid pseudopapillary neoplasm of the pancreas (SPN) patients recruited in PUMCH from 2001 to 2026. The quality of life is evaluated by a questionnaire made up of eight validated scales.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Jan 2001

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jan 2001Aug 2026

Study Start

First participant enrolled

January 1, 2001

Completed
21.8 years until next milestone

First Submitted

Initial submission to the registry

October 10, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 3, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

November 3, 2022

Status Verified

November 1, 2022

Enrollment Period

24.6 years

First QC Date

October 10, 2022

Last Update Submit

November 1, 2022

Conditions

Keywords

Solid Pseudopapillary Neoplasm of the Pancreassurgeryfollow updigestive physiological functionsocial psychological function

Outcome Measures

Primary Outcomes (1)

  • scores of digestive physiological and social psychological functions

    The primary outcome is a score of digestive physiological and social psychological functions of SPN patients up to 15 years after surgery. The score is evaluated by a follow-up questionnaire made up of: digestive physiological functions via 8 symptoms scale of the EORTC core quality of life questionnaire and gastrointestinal symptom rating scale questionnaire; social psychological functions via sense of coherence-9, patient health questionnaire-9, general anxiety disorder-7; post-traumatic embitterment disorder 21; work ability index questionnaire, body image scale.R aw scores will undergo a linear transformation for standardization. The maximum and minimum score is 100 and 0, respectively. Higher scores on the digestive physiological and social psychological functioning scales represent better quality of life, whereas higher scores on the symptom scale represent more serious symptoms or poorer quality of life.

    up to 15 years after surgery

Secondary Outcomes (1)

  • progressive-free survival

    the time from the surgery to the progressive conditions (From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to up 180 months)

Study Arms (1)

SPN patients

Other: observational study

Interventions

observational study

SPN patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All of the hospitalized patients of SPN with a definite pathological diagnosis who underwent operations from 2001 to 2026 in Peking Union Medical College Hospital

You may qualify if:

  • SPN patients with pathological diagnosis after surgery
  • Approval to participate
  • patients with valid and complete questionnaires results inspected by two experienced surgeons

You may not qualify if:

  • Refusal to participate
  • patients with invalid or incomplete questionnaires results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

RECRUITING

MeSH Terms

Conditions

Pancreatic Neoplasms

Interventions

Observation

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Qiaofei Liu

    Department of General Surgery, Peking Union Medical College Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical chief professor

Study Record Dates

First Submitted

October 10, 2022

First Posted

November 3, 2022

Study Start

January 1, 2001

Primary Completion

August 1, 2025

Study Completion (Estimated)

August 1, 2026

Last Updated

November 3, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations